Introduction The rising cost of medications has emerged as a pressing concern for patients and healthcare systems worldwide. Recently, Eli Lilly announced a price increase for their diabetes and weight loss medication, Mounjaro, in the United Kingdom. This development has sparked discussions about the implications for patients who rely on this drug for managing their